Considering Equity and Consumer Impacts of GLP-1 Drugs – A UBS Economist Weighs In
Jane Sarashon
APRIL 8, 2024
As Donovan notes, “GLP-1 medication is not cheap if purchased by a private individual,” estimating that only one in five adults has insurance that would cover anti-obesity medication. ” Health Populi’s Hot Points : Brand Keys published its 21st annual survey on the most innovative brands conducted among U.S.
Let's personalize your content